Atlas Trials

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

Clinical trial NCT05698212 · RECRUITING

Trial details

NCT number
NCT05698212
Sponsor
Hera Biotech, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
EndometriosisDiagnosis
Start date
2022-09-14
Primary completion
2023-03-25
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.